GlassScriptPhysician profile
Bradley C Herpolsheimer
NPI 1518087881
$1,068.98
in general payments reported to CMS, 2019-2025
19 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $644 · 2020: $45.63 · 2021: $30.13 · 2022: $52.36 · 2023: $49.43 · 2024: $17.20 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $313.03 | 2019-2023 | |
| Glaxosmithkline, LLC. | $216.60 | 2019 | |
| Novo Nordisk INC | $144.86 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.00 | 2025 | Trintellix |
| Abbvie INC. | $65.89 | 2021-2025 | |
| Astellas Pharma US INC | $35.00 | 2025 | Veozah |
| Acadia Pharmaceuticals INC | $20.60 | 2025 | Nuplazid |
| Vertical Pharmaceuticals, LLC | $20.28 | 2025 | Relexxii |
| Exact Sciences Corporation | $19.43 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $19.20 | 2022 | |
| Amgen INC. | $17.81 | 2019 | |
| Eisai INC. | $17.20 | 2024 | |
| Xeris Pharmaceuticals, INC. | $16.65 | 2023 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $16.62 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.54 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $16.27 | 2025 | Tymlos |
| Genentech USA, INC. | $15.93 | 2020 | |
| Jazz Pharmaceuticals INC. | $15.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.07 | 2023 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Herpolsheimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.